Antihistamines used in Visual Snow Syndrome primarily target H1 receptors, potentially modulating neurotransmitter signaling and reducing neurological hyperexcitability. They may help mitigate visual disturbances by dampening cortical and thalamic neuronal hyperactivity, though their efficacy remains under investigation with limited clinical evidence.